From: Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives
Drug name | Chemical structure | Phase | Cancer | Clinical trials identifier | Ref |
---|---|---|---|---|---|
CQ |
| I | glioblastoma | NCT02378532 | [193] |
HCQ |
| II | Non-Small Cell Lung Cancer | NCT04735068 | [194] |
ABTL0812 |
| I | solid tumours | NCT02201823 | [195] |
Sirolimus |
| I | Lymphangioleiomyomatosis | NCT01687179 | [196] |
temsirolimus |
| I | melanoma | NCT00281957 | [197] |
Pantoprazole |
| II | Metastatic Castration-Resistant Prostate Cancer | NCT01748500 | [198] |
2-OHOA |
| I | glioma | NCT01792310 | [199] |
Neratinib |
| I | pancreatic cancer | NCT02349867 | [200] |